Ledger Susan St. - 15 May 2024 Form 4 Insider Report for Klaviyo, Inc. (KVYO)

Role
Director
Signature
/s/ Landon Edmond, Attorney-in-Fact
Issuer symbol
KVYO
Transactions as of
15 May 2024
Net transactions value
-$258,930
Form type
4
Filing time
17 May 2024, 16:40:20 UTC
Previous filing
22 Mar 2024
Next filing
13 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVYO Series A Common Stock Conversion of derivative security +10,500 10,500 16 May 2024 Direct F1
transaction KVYO Series A Common Stock Sale $258,930 -10,500 -100% $24.66 0 16 May 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVYO Series B Common Stock Conversion of derivative security $0 -10,500 -15% $0.000000 59,500 15 May 2024 Series A Common Stock 10,500 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
F2 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
F3 Consists of (i) 12,833 shares of Series B Common Stock and (ii) 46,667 unvested restricted stock units awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.